HAMED KAMAL 4
4 · Spero Therapeutics, Inc. · Filed Feb 3, 2023
Insider Transaction Report
Form 4
HAMED KAMAL
Chief Medical Officer
Transactions
- Award
Common Stock
2023-02-01+265,957→ 475,957 total
Footnotes (2)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]Includes 475,957 RSUs held by the Reporting Person.